162 related articles for article (PubMed ID: 17617868)
1. Human islet function is not impaired by the sphingosine-1-phosphate receptor modulator FTY720.
Truong W; Emamaullee JA; Merani S; Anderson CC; James Shapiro AM
Am J Transplant; 2007 Aug; 7(8):2031-8. PubMed ID: 17617868
[TBL] [Abstract][Full Text] [Related]
2. Long-term islet graft survival in streptozotocin- and autoimmune-induced diabetes models by immunosuppressive and potential insulinotropic agent FTY720.
Fu F; Hu S; Deleo J; Li S; Hopf C; Hoover J; Wang S; Brinkmann V; Lake P; Shi VC
Transplantation; 2002 May; 73(9):1425-30. PubMed ID: 12023620
[TBL] [Abstract][Full Text] [Related]
3. Novel sphingosine-1-phosphate receptor modulator KRP203 combined with locally delivered regulatory T cells induces permanent acceptance of pancreatic islet allografts.
Khattar M; Deng R; Kahan BD; Schroder PM; Phan T; Rutzky LP; Stepkowski SM
Transplantation; 2013 Apr; 95(7):919-27. PubMed ID: 23545505
[TBL] [Abstract][Full Text] [Related]
4. Islet allograft survival in nonhuman primates immunosuppressed with basiliximab, RAD, and FTY720.
Wijkstrom M; Kenyon NS; Kirchhof N; Kenyon NM; Mullon C; Lake P; Cottens S; Ricordi C; Hering BJ
Transplantation; 2004 Mar; 77(6):827-35. PubMed ID: 15077021
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine 1-phosphate receptor modulators: a new class of immunosuppressants.
Yopp AC; Ledgerwood LG; Ochando JC; Bromberg JS
Clin Transplant; 2006; 20(6):788-95. PubMed ID: 17100731
[TBL] [Abstract][Full Text] [Related]
6. FTY720, a novel immunosuppressive agent with insulinotropic activity, prolongs graft survival in a mouse islet transplantation model.
Fu F; Hu S; Li S; DeLeo J; Hoover J; Wang S; Lake P; Shi V
Transplant Proc; 2001; 33(1-2):672-3. PubMed ID: 11267010
[No Abstract] [Full Text] [Related]
7. Targeting lymphangiogenesis after islet transplantation prolongs islet allograft survival.
Yin N; Zhang N; Xu J; Shi Q; Ding Y; Bromberg JS
Transplantation; 2011 Jul; 92(1):25-30. PubMed ID: 21508896
[TBL] [Abstract][Full Text] [Related]
8. Effect of a new immunosuppressive agent, FTY720, on survival of islet allografts.
Yamasaki T; Inoue K; Hayashi H; Gu Y; Setoyama H; Ida J; Cui W; Kawakami Y; Kogire M; Imamura M
Cell Transplant; 1998; 7(4):403-6. PubMed ID: 9710310
[TBL] [Abstract][Full Text] [Related]
9. The imbalance between Treg and Th17 cells caused by FTY720 treatment in skin allograft rejection.
Commodaro AG; Pedregosa JF; Peron JP; Brandão W; Rizzo LV; Bueno V
Clinics (Sao Paulo); 2012 Jul; 67(7):805-13. PubMed ID: 22892927
[TBL] [Abstract][Full Text] [Related]
10. [New therapeutic approach for autoimmune diseases by the sphingosine 1-phosphate receptor modulator, fingolimod (FTY720)].
Chiba K
Yakugaku Zasshi; 2009 Jun; 129(6):655-65. PubMed ID: 19483408
[TBL] [Abstract][Full Text] [Related]
11. FTY720 in combination with CsA inhibits islet xenograft rejection: a study in the pig-to-rat model.
Zhang J; Song Z; Wijkström M; Bari S; Sundberg B; Nava S; Groth CG; Korsgren O; Wennberg L
Transplant Proc; 2000 Aug; 32(5):1017. PubMed ID: 10936327
[No Abstract] [Full Text] [Related]
12. [A new therapeutic approach for autoimmune diseases by the sphingosine 1-phosphate receptor modulator, fingolimod (FTY720)].
Chiba K
Nihon Rinsho Meneki Gakkai Kaishi; 2009 Apr; 32(2):92-101. PubMed ID: 19404007
[TBL] [Abstract][Full Text] [Related]
13. Ascomycete derivative to MS therapeutic: S1P receptor modulator FTY720.
Hiestand PC; Rausch M; Meier DP; Foster CA
Prog Drug Res; 2008; 66():361, 363-81. PubMed ID: 18416311
[TBL] [Abstract][Full Text] [Related]
14. Combination effect of tacrolimus and FTY720 in liver transplantation in rats.
Tamura A; Li XK; Funeshima N; Enosawa S; Amemiya H; Suzuki S
Transplant Proc; 1999 Nov; 31(7):2785-6. PubMed ID: 10578290
[No Abstract] [Full Text] [Related]
15. FTY720 (s)-phosphonate preserves sphingosine 1-phosphate receptor 1 expression and exhibits superior barrier protection to FTY720 in acute lung injury.
Wang L; Sammani S; Moreno-Vinasco L; Letsiou E; Wang T; Camp SM; Bittman R; Garcia JG; Dudek SM
Crit Care Med; 2014 Mar; 42(3):e189-99. PubMed ID: 24335440
[TBL] [Abstract][Full Text] [Related]
16. The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators.
Soliven B; Miron V; Chun J
Neurology; 2011 Feb; 76(8 Suppl 3):S9-14. PubMed ID: 21339490
[TBL] [Abstract][Full Text] [Related]
17. Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats.
Hasegawa Y; Suzuki H; Sozen T; Rolland W; Zhang JH
Stroke; 2010 Feb; 41(2):368-74. PubMed ID: 19940275
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppression with FTY720 and cyclosporine A inhibits rejection of adult porcine islet xenografts in rats.
Maeda A; Goto M; Zhang J; Bennet W; Groth CG; Korsgren O; Wennberg L
Transplantation; 2003 Apr; 75(8):1409-14. PubMed ID: 12717240
[TBL] [Abstract][Full Text] [Related]
19. FTY720 preserved islet β-cell mass by inhibiting apoptosis and increasing survival of β-cells in db/db mice.
Moon H; Chon J; Joo J; Kim D; In J; Lee H; Park J; Choi J
Diabetes Metab Res Rev; 2013 Jan; 29(1):19-24. PubMed ID: 22936676
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo.
Hu Y; Lee X; Ji B; Guckian K; Apicco D; Pepinsky RB; Miller RH; Mi S
Mol Cell Neurosci; 2011 Sep; 48(1):72-81. PubMed ID: 21740973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
